Lakewood-Amedex Biotherapeutics Inc. Company Profile
NASDAQ: LABTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Lakewood-Amedex Biotherapeutics at a glance
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) is a Biotechnology company in the Healthcare sector headquartered in University Park, FL. Lakewood-Amedex Biotherapeutics is led by Dr. Kelvin Cooper Ph.D. and employs about 5 people. At a market capitalization of $1.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002079272, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Lakewood-Amedex Biotherapeutics do?
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- Lakewood-Amedex Biotherapeutics Inc.
- Ticker
- NASDAQ: LABT
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Kelvin Cooper Ph.D.
- Employees
- 5
- Headquarters
- 8031 Cooper Creek Blvd., University Park, FL, United States
- Phone
- 941 225 2515
- Website
- lakewoodamedex.com
- Market cap
- $1.88M
- SEC CIK
- 0002079272
Companies similar to Lakewood-Amedex Biotherapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ARTLArtelo Biosciences Inc. | 3.37 | -1.17% | $1.85M | vs LABT |
| VBIOValion Bio Inc. | 2.21 | +0.91% | $1.96M | vs LABT |
| EDVAEndovia Health Sciences Inc. | 0.1599 | -3.09% | $1.77M | vs LABT |
| CRISCuris Inc. | 0.7094 | -3.69% | $1.72M | vs LABT |
| OGENOragenics Inc. | 0.463 | -7.38% | $2.09M | vs LABT |
| SCNIScinai Immunotherapeutics Ltd. ADR | 1.21 | +7.08% | $1.64M | vs LABT |
| GNPXGenprex Inc. | 2.75 | +4.96% | $2.25M | vs LABT |
| TCRTAlaunos Therapeutics Inc. | 0.781 | -6.70% | $2.29M | vs LABT |